Novel preclinical model for CDKL5 deficiency disorder
Rita J Serrano1, Clara Lee1, Alon M Douek2
1School of Biological Sciences, Monash University, Melbourne 3800, Australia.
Disease Models & Mechanisms
|December 16, 2021
Summary
A new zebrafish model for Cyclin-dependent kinase-like-5 (CDKL5) deficiency disorder (CDD) shows disease-relevant defects. This model will aid in discovering effective therapies for this severe neurodevelopmental condition.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- Cyclin-dependent kinase-like-5 (CDKL5) deficiency disorder (CDD) is a severe X-linked neurodegenerative disease impacting neurological and motor functions.
- Current treatments for CDD focus on symptom management, lacking therapies that address the underlying pathology.
Purpose of the Study:
- To characterize a novel loss-of-function zebrafish model for CDD.
- To establish a platform for high-throughput screening of potential CDD therapies.
Main Methods:
- Generated a zebrafish model with a nonsense mutation in the cdkl5 gene.
- Assessed neurological and motor phenotypes, including neuronal patterning, seizures, microcephaly, and muscle innervation.
Main Results:
- The cdkl5 mutant zebrafish exhibited significant defects mirroring human CDD symptoms.
- Observed impaired muscle innervation leading to reduced muscle function.
- Confirmed the utility of zebrafish for studying CDD pathophysiology.
Conclusions:
- The characterized zebrafish model provides a powerful tool for investigating CDD.
- This model facilitates high-throughput screening for novel therapeutic strategies for CDD.
